ROYAL BANK OF CANADA - INMED PHARMACEUTICALS INC ownership

INMED PHARMACEUTICALS INC's ticker is INM and the CUSIP is 457637502. A total of 20 filers reported holding INMED PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of INMED PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$02500.0%0.00%
Q1 2022$0
-100.0%
250
-37.7%
0.00%
Q4 2021$1,000401
+60.4%
0.00%
Q3 2021$0
-100.0%
2500.0%0.00%
Q2 2021$1,000
-50.0%
250
-57.3%
0.00%
Q1 2021$2,000
+100.0%
586
+142.1%
0.00%
Q4 2020$1,0002420.00%
Other shareholders
INMED PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
AllSquare Wealth Management LLC 545$1,0000.00%
TWO SIGMA ADVISERS, LP 205,800$270,0000.00%
Creative Planning 10,832$14,0000.00%
ROYAL BANK OF CANADA 401$1,0000.00%
Carroll Financial Associates, Inc. 136$00.00%
TCI Wealth Advisors, Inc. 125$00.00%
TWO SIGMA INVESTMENTS, LP 131,673$172,0000.00%
OSAIC HOLDINGS, INC. 1,185$1,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
HC FINANCIAL ADVISORS INC 24$00.00%
View complete list of INMED PHARMACEUTICALS INC shareholders